It seems that after an initial frenzy at the start of the COVID-19 pandemic, when seemingly almost any old test could somehow make it on the market (check out the April news review for comments on quality issues), we’ve seen not just quality tests but also kits with added features appear from summer 2020. More and more COVID-19 tests have been […]
COVID-19 has had a huge impact on various industries including manufacturing, travel & tourism as well as life sciences and healthcare. When we talk about ‘industries’, inevitably we talk about human lives. Let’s look beyond the immediate turmoil into which many have been thrust. With the world around us changing at a seemingly accelerated speed, what’s out there to help […]
Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, test kits are becoming more elaborate; repurposed drugs promise to accelerate recovery; and vaccine development is in full swing globally with Russia having already approved […]
Convalescent plasma (CP) therapy gained FDA emergency use authorisation (EUA) in August. It appears that this is surrounded by some controversy and suspicion of politicisation. Without getting anywhere near politics here, let’s not forget that health agencies’ interest in CP is nothing new. The FDA has previously encouraged survivors to donate plasma and supported developments in this space along with […]